Bruce C. Cozadd
Chairman & CEO at Jazz Pharmaceuticals plc
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Jazz Pharmaceuticals plc, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Jazz Pharmaceuticals plc July 23, 202696.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 6, 2026 | Jazz Pharmaceuticals plc | Option exercise | +734 | $136.18 | $99,956 |
| Nov 6, 2026 | Jazz Pharmaceuticals plc | Option exercise | +85,766 | $136.18 | $11,679,614 |
| Nov 6, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −27,714 | $234.91 | $6,510,357 |
| Nov 6, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −10,688 | $235.82 | $2,520,466 |
| Nov 6, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −24,483 | $236.84 | $5,798,652 |
| Nov 6, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −5,923 | $237.39 | $1,406,043 |
| Nov 2, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −6,000 | $215.84 | $1,295,040 |
| Oct 1, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −6,000 | $230.33 | $1,381,980 |
| Sep 1, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −6,000 | $250.13 | $1,500,780 |
| Aug 31, 2026 | Jazz Pharmaceuticals plc | Shares withheld for tax | −10 | $244.06 | $2,441 |
| Aug 31, 2026 | Jazz Pharmaceuticals plc | Shares withheld for tax | −1,209 | $241.39 | $291,841 |
| Aug 5, 2026 | Jazz Pharmaceuticals plc | Grant or award | +1,605 | — | — |
| Aug 3, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −6,000 | $252.98 | $1,517,880 |
| Jul 1, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −6,000 | $240.47 | $1,442,820 |
| Jun 1, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −6,000 | $235.12 | $1,410,720 |
Questions about Bruce C. Cozadd
What boards is Bruce C. Cozadd on?
Bruce C. Cozadd sits on the board of Jazz Pharmaceuticals plc.
What company is Bruce C. Cozadd the CEO of?
Bruce C. Cozadd is Chairman & CEO of Jazz Pharmaceuticals plc.
How long has Bruce C. Cozadd served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.